Tibet Rhodiola Pharmaceutical Holding Co. develops, manufactures, and markets Tibet medicines.  The Company's products include Rhodiola capsules, Rhodiola pellets, and other related medicines.

Announcement on the Convening of the Semi-annual and Q3 2024 Performance Briefing

Report on the Implementation of Major Asset Purchase

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Tibet Rhodiola Pharm A (600211 CH)

Announcement on the Convening of the Semi-annual and Q3 2024 Performance Briefing

Report on the Implementation of Major Asset Purchase

Announcement on the Completion of the Significant Asset Restructuring of Yi Mu Duo

Report for Q3 2024

Announcement on Obtaining Approval for Drug Supplement Application for Imdur (Chinese Market)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)